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The introduction of Highly Active Antiretroviral Therapy
has transformed HIV-infectionf r o ma ni n e v i t a b l yl e t h a l
d i s e a s et oac h r o n i cc o n d i t i o nw i t hal i f ee x p e c t a n c y
comparable to that of people with diabetes mellitus.
In recent years it has become evident that people liv-
ing with HIV/AIDS have an increased risk of developing
cardiovascular disease and it is expected that the preva-
lence of chronic kidney disease will rise accordingly. To
investigate the prevalence of chronic kidney disease in
patients with HIV we conducted a retrospective observa-
tional analysis using the clinical database of a large cen-
tre (Institute of Tropical Medicine) in the urban area of
Antwerp, Belgium. The prevalence of chronic kidney
disease among HIV infected subjects was found to be
3.0%. The development of chronic kidney disease was
associated with age above 50 years, lower CD4 cell
counts and Caucasian origin. Screening for chronic
renal disorders and prevention of evolution toward
chronic renal failure is a crucial challenge in the man-
agement of people living with HIV/AIDS.
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